ATE194777T1 - Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base - Google Patents
Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine baseInfo
- Publication number
- ATE194777T1 ATE194777T1 AT95916656T AT95916656T ATE194777T1 AT E194777 T1 ATE194777 T1 AT E194777T1 AT 95916656 T AT95916656 T AT 95916656T AT 95916656 T AT95916656 T AT 95916656T AT E194777 T1 ATE194777 T1 AT E194777T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclodextrin
- base
- inclusion complexes
- acidic drug
- multiple component
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 230000002378 acidificating effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI940790A IT1269578B (it) | 1994-04-22 | 1994-04-22 | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| PCT/EP1995/001407 WO1995028965A1 (en) | 1994-04-22 | 1995-04-13 | High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE194777T1 true ATE194777T1 (de) | 2000-08-15 |
Family
ID=11368715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95916656T ATE194777T1 (de) | 1994-04-22 | 1995-04-13 | Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5773029A (de) |
| EP (1) | EP0756493B1 (de) |
| AT (1) | ATE194777T1 (de) |
| AU (1) | AU2307695A (de) |
| CA (1) | CA2188388A1 (de) |
| DE (1) | DE69518070T2 (de) |
| ES (1) | ES2148512T3 (de) |
| IL (1) | IL113450A (de) |
| IT (1) | IT1269578B (de) |
| PT (1) | PT756493E (de) |
| WO (1) | WO1995028965A1 (de) |
| ZA (1) | ZA953206B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997018245A1 (en) * | 1995-11-14 | 1997-05-22 | Farmarc Nederland B.V. | Complex of naproxen and beta-cyclodextrin |
| UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
| DE69730902T2 (de) * | 1996-05-07 | 2006-02-23 | Pfizer Inc. | Verfahren zur Selektion eines Salzes zur Herstellung eines Inklusionskomplexes |
| US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| US6939863B2 (en) | 2002-01-04 | 2005-09-06 | Wei-Jan Chen | Prevention of atherosclerosis and restenosis |
| EP1492511B3 (de) | 2002-04-09 | 2012-05-02 | Flamel Technologies | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
| EP1374906B1 (de) * | 2002-06-17 | 2007-04-18 | CHIESI FARMACEUTICI S.p.A. | Prozess für die Vorbereitung von Piroxicam: Beta-Cyclodextrin Einschlusskomplexe |
| ATE428423T1 (de) * | 2002-08-20 | 2009-05-15 | Bristol Myers Squibb Co | Aripiprazol-komplex-formulierung und verfahren |
| DE10260872B4 (de) * | 2002-12-23 | 2013-09-26 | Beiersdorf Ag | Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices |
| DE10260873A1 (de) | 2002-12-23 | 2004-07-15 | Beiersdorf Ag | Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin |
| US7993654B2 (en) | 2002-12-23 | 2011-08-09 | Beiersdorf Ag | Self-adhesive polymer matrix containing sea algae extract |
| US20070020578A1 (en) * | 2005-07-19 | 2007-01-25 | Scott Robert R | Dental curing light having a short wavelength LED and a fluorescing lens for converting wavelength light to curing wavelengths and related method |
| US20080171687A1 (en) * | 2004-09-16 | 2008-07-17 | Abraxis Bioscience, Inc. | Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
| WO2007069274A2 (en) * | 2005-11-09 | 2007-06-21 | Torrent Pharmaceuticals Limited | Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent |
| FR2914187B1 (fr) * | 2007-03-28 | 2011-01-21 | Pf Medicament | Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique. |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| PL2434886T3 (pl) | 2009-05-29 | 2020-05-18 | Cydex Pharmaceuticals, Inc. | Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania |
| CN108210501B (zh) * | 2016-12-14 | 2019-03-08 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种磺酰脲类药物的注射用药物组合物及其制备方法 |
| CA3210407A1 (en) | 2021-03-04 | 2022-09-09 | Kenny K. Tran | Low-sorbing glyburide formulation and methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| GR880100854A (el) * | 1987-12-22 | 1994-03-31 | Glaxo Group Ltd | Υδατικές διαμορφώσεις που περιέχουν ενα παράγωγο πιπεριδινυλκυκλοπεντυλεπτενοικού οξέος. |
| IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
-
1994
- 1994-04-22 IT ITMI940790A patent/IT1269578B/it active IP Right Grant
-
1995
- 1995-04-13 ES ES95916656T patent/ES2148512T3/es not_active Expired - Lifetime
- 1995-04-13 AU AU23076/95A patent/AU2307695A/en not_active Abandoned
- 1995-04-13 WO PCT/EP1995/001407 patent/WO1995028965A1/en not_active Ceased
- 1995-04-13 PT PT95916656T patent/PT756493E/pt unknown
- 1995-04-13 CA CA002188388A patent/CA2188388A1/en not_active Abandoned
- 1995-04-13 AT AT95916656T patent/ATE194777T1/de not_active IP Right Cessation
- 1995-04-13 EP EP95916656A patent/EP0756493B1/de not_active Expired - Lifetime
- 1995-04-13 US US08/722,220 patent/US5773029A/en not_active Expired - Fee Related
- 1995-04-13 DE DE69518070T patent/DE69518070T2/de not_active Expired - Fee Related
- 1995-04-20 ZA ZA953206A patent/ZA953206B/xx unknown
- 1995-04-20 IL IL11345095A patent/IL113450A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2307695A (en) | 1995-11-16 |
| IL113450A (en) | 1999-05-09 |
| ZA953206B (en) | 1996-01-03 |
| IT1269578B (it) | 1997-04-08 |
| PT756493E (pt) | 2000-10-31 |
| CA2188388A1 (en) | 1995-11-02 |
| WO1995028965A1 (en) | 1995-11-02 |
| IL113450A0 (en) | 1995-07-31 |
| EP0756493B1 (de) | 2000-07-19 |
| ITMI940790A0 (it) | 1994-04-22 |
| DE69518070D1 (de) | 2000-08-24 |
| ITMI940790A1 (it) | 1995-10-22 |
| HK1013627A1 (en) | 1999-09-03 |
| EP0756493A1 (de) | 1997-02-05 |
| DE69518070T2 (de) | 2001-01-11 |
| US5773029A (en) | 1998-06-30 |
| ES2148512T3 (es) | 2000-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE194777T1 (de) | Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base | |
| DK1036058T3 (da) | Adamantanderivater | |
| DE69808130D1 (de) | Adamantan-derivate | |
| SE9704546D0 (sv) | Novel compounds | |
| DE69005359D1 (de) | Poröse Einheitsform und Verfahren. | |
| ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
| ATE174905T1 (de) | Wasserlösliche organische salze von kreatin | |
| IT1243193B (it) | Composizioni farmaceutiche orali a base di melatonina | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
| DK0468258T3 (da) | Substituerede pyridooxaziner | |
| RU98116380A (ru) | Применение ингибиторов натрий-водородного обмена для получения лекарственного средства в целях лечения заболеваний, вызываемых простейшими | |
| NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| DE3878988D1 (de) | 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt. | |
| ATE222255T1 (de) | 14-substituierte marcfortine und derivate als antiparasitäre mittel | |
| FR2663219B1 (fr) | Fauteuil pour traitements medicaux. | |
| HRPK921028B1 (en) | Binder for heat-set colours | |
| DE59609482D1 (de) | Anellierte beta-carboline | |
| BR8002983U (pt) | Beliche guarda-roupa e escrivaninha | |
| IT8904963V0 (it) | Calendario da tavolo. | |
| ATE49956T1 (de) | N,n-bis-(4fluorophenyl)carbamoylacetohydroxams|ure und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |